Skip to main content
IC
Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
0.6640
-0.0260 (-3.77%)
May 14, 2025, 1:00 PM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Novel Treatments for Multi-drug Resistant Bacterial Infections
103.78M
Log In
Log In
Log In
Log In
Upgrade
Novel Treatments for Multi-drug Resistant Bacterial Infections Growth
93.95%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
103.78M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
93.95%
Log In
Log In
Log In
Log In
Upgrade